
Friday, July 12, 2024 10:16:40 AM
I'm assuming you've all seen this ?
So the key pt ...other than active inducement
” After Hikma’s ANDA was approved, Hikma issued a series of press releases that referred to its product as a “generic” version of Vascepa, even though the product was not approved for the cardiovascular risk indication.
So risk is only to those generics that refer to their product as ...a generic version of Vascepa ?
Kiwi
Recent AMRN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2025 11:05:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 11:05:10 AM
- Amarin Reports First Quarter 2025 Financial Results • GlobeNewswire Inc. • 05/07/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2025 08:20:08 PM
- Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 04/29/2025 08:15:00 PM
- Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 • GlobeNewswire Inc. • 04/28/2025 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:03 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/11/2025 10:00:07 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2025 09:01:21 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2025 11:30:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2025 11:35:08 AM
- Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change • GlobeNewswire Inc. • 04/09/2025 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2025 11:25:08 AM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 04/07/2025 11:50:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2025 11:40:08 AM
- Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors • GlobeNewswire Inc. • 04/07/2025 11:30:00 AM
- Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist • GlobeNewswire Inc. • 03/31/2025 12:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/28/2025 08:45:14 PM
Lingerie Fighting Championships Coming to the UK for July 4 & 6 Events • BOTY • May 19, 2025 10:00 AM
VAYK Projects to Report Over $400K Q1 Revenue • VAYK • May 15, 2025 9:00 AM
Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone • VRHI • May 15, 2025 8:00 AM
Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer • BLO • May 14, 2025 8:51 AM
North Bay Resources Announces Resource Estimate of 474,000 ounces at Fran Gold Project, British Columbia • NBRI • May 13, 2025 9:58 AM
UC Asset Filed for Public Offering of 8% Dividend Preferred Units • UCASU • May 12, 2025 9:55 AM